Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01741805

The Clinical and Laboratory Phenotypes of Severe Asthma Patients in Clalit Health Services Haifa

The Clinical and Laboratory Phenotypes of Severe Asthma Patients in Clalit Health Services Haifa.

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Carmel Medical Center · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Asthma is a chronic illness characterized by inflammation of the airways. Severe asthma is defined in the literature as asthma not controlled by medication. In recent years it has become known that severe asthma is a variable disease and has subtypes relating to the age of onset, type of inflammation and allergy, obesity, etc. Our aim is to characterize the phenotypes of severe asthma population in our clinic and compare the prevalent phenotypes to the phenotypes described before.

Detailed description

Study measures will include the following: * asthma demographic and symptoms questionnaire * Validation of proper inhaler technique * Height, weight measurements * Forced spirometry and reversibility testing * DLCO * Fractional excretion of NO in exhaled breath * Chest and sinus CT * Induced sputum analysis * Complete blood count, electrolytes, immunoglobulin E, Aspergillus Specific IgE * Skin allergy testing

Conditions

Interventions

TypeNameDescription
OTHERSevere AsthmaDemographic data, Spirometry, induced sputum, IgE, Aspergillus specific IgE

Timeline

Start date
2012-12-01
Primary completion
2013-11-01
Completion
2014-04-01
First posted
2012-12-05
Last updated
2016-07-29

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01741805. Inclusion in this directory is not an endorsement.